Cell Therapy Market 2020

1
Cell Therapy Market 2020-2023
Industry Survey, Growth, Competitive
Landscapeand Forecasts to 2023
2
Cell Therapy Market 2020-2023
Cell Therapy Market Highlights
The global cell therapy market is estimated to be
valued at USD 20,217.00 million by 2023 and is
expected to register a CAGR of 22.36 during the
forecast period. The autologous segment is
expected to lead the market and register a
substantial CAGR to reach USD 11,554.67 million
by the end of 2023. Autologous cell therapy is a
branch of regenerative medicine. It involves
biologic cell-based therapies to cure various
diseases related to oncology, dermatology, and
neurology, among others. Autologous cell therapy
is anticipated to hold a significant share of the
market as compared to allogeneic cell
therapy Americas accounted for the largest market
share of 37.6 in 2017, and the regional market
is projected to register a CAGR of 21.45 during
the forecast period. North America is one of the
leading markets in the region, accounting for the
largest market share during the review
period. 

3
Cell Therapy Market 2020-2023
Cell Therapy Market Segmental Analysis
By type, the global cell therapy market has been
classified as autologous and allogeneic. Based on
product, the global cell therapy market has been
classified as consumables (vessel/media/serum/reag
ent), equipment, software other services. On
the basis of technique the global cell therapy
market has been classified as stem cell therapy,
cell vaccine, adoptive cell transfer (act),
fibroblast cell therapy and chondrocyte cell
therapy. By technology the global cell therapy
market has been classified as viral vector
technology, cell immortalization technology, and
genome editing technology. Based on cell source
the global cell therapy market has been
classified as bone marrow, adipose tissue, and
umbilical cord blood-derived cells.
4
Cell Therapy Market 2020-2023
Cell Therapy Market Regional Analysis
Geographically, the global cell therapy market
has been segmented into North America, Europe,
Asia-Pacific, and the rest of the world. As per
MRFR analysis, North America holds the largest
market for cell therapy in 2017 and is expected
to remain dominant during the review period.
Europe accounted for a significant market share
and is projected to be the second-largest market
during the forecast period. The rise in the
demand for cell therapy for the treatment of
oncology is a major driving factor for the growth
of the cell therapy market in Europe. Browse Com
plete Report with TOC _at_ https//www.marketresearch
future.com/reports/cell-therapy-market-5066
5
Cell Therapy Market 2020-2023
Cell Therapy Market Key Players

• Mesoblast Ltd
• Vericel Corporation
• Osiris Therapeutics, Inc
• JCR Pharmaceuticals Co., Ltd
• NuVasive, Inc.
• Pharmicell Co., Ltd
• RTI Surgical Holdings, Inc.
• AlloSource
• Holostem Terapie Avanzate S.r.l.
• Avail Free Sample _at_ https//www.marketresearchfutu
  re.com/sample_request/5066

6
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
7
(No Transcript)